These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20679544)

  • 1. Comparative effectiveness research: a progress report.
    Sox HC
    Ann Intern Med; 2010 Oct; 153(7):469-72. PubMed ID: 20679544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness research: does the emperor have clothes?
    Coulter ID
    Altern Ther Health Med; 2011; 17(2):8-15. PubMed ID: 21717820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Science and the stiumulus. Medicine under the microscope.
    Marshall E
    Science; 2009 Nov; 326(5957):1183-5. PubMed ID: 19965447
    [No Abstract]   [Full Text] [Related]  

  • 4. How a unique provision in the American Recovery and Reinvestment Act set a foundation for the Patient-Centered Outcomes Research Institute.
    Selby J; Slutsky J
    J Comp Eff Res; 2014 Nov; 3(6):565-6. PubMed ID: 25494560
    [No Abstract]   [Full Text] [Related]  

  • 5. Five next steps for a new national program for comparative-effectiveness research.
    VanLare JM; Conway PH; Sox HC
    N Engl J Med; 2010 Mar; 362(11):970-3. PubMed ID: 20164480
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of comparative effectiveness research on interventional pain management: evolution from Medicare Modernization Act to Patient Protection and Affordable Care Act and the Patient-Centered Outcomes Research Institute.
    Manchikanti L; Falco FJ; Benyamin RM; Helm S; Parr AT; Hirsch JA
    Pain Physician; 2011; 14(3):E249-82. PubMed ID: 21587337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of recent federal spending on comparative effectiveness research: priorities, gaps, and next steps.
    Benner JS; Morrison MR; Karnes EK; Kocot SL; McClellan M
    Health Aff (Millwood); 2010 Oct; 29(10):1768-76. PubMed ID: 20921474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Science and the stimulus. Science and the stimulus.
    Mervis J
    Science; 2009 Nov; 326(5957):1176-7. PubMed ID: 19965443
    [No Abstract]   [Full Text] [Related]  

  • 9. Lessons from comparative effectiveness research methods development projects funded under the Recovery Act.
    Zurovac J; Esposito D
    J Comp Eff Res; 2014 Nov; 3(6):601-7. PubMed ID: 25494566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The American Reinvestment and Recovery Act investment in comparative effectiveness research: lessons learned and implications for future investments.
    Dormer L; Greenfield S
    J Comp Eff Res; 2014 Nov; 3(6):559. PubMed ID: 25494558
    [No Abstract]   [Full Text] [Related]  

  • 11. The ARRA investment in CER: a description of the midstream evaluation and how the funds were allocated and CER priorities addressed.
    Esposito D; Yong PL; Rich E; Geonnotti K; Kimmey LD
    J Comp Eff Res; 2014 Nov; 3(6):581-9. PubMed ID: 25494564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research funding.
    He B
    IEEE Eng Med Biol Mag; 2009; 28(3):4. PubMed ID: 21462408
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessing the long-term impact of public investments in comparative effectiveness research: conceptual framework and lessons learned.
    Rich EC; Esposito D; Kimmey LD; Valenzano CS; Yong PL
    J Comp Eff Res; 2014 Nov; 3(6):657-66. PubMed ID: 25494572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spending limited health care dollars on what works best: the promise of comparative effectiveness research.
    Stein J
    N C Med J; 2010; 71(3):265-6. PubMed ID: 20681501
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative effectiveness research (CER): a summary of AHRQ's CER on therapies for rheumatoid arthritis.
    Oderda GM; Balfe LM
    J Manag Care Pharm; 2011; 17(9 Suppl B):S19-24. PubMed ID: 22073936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating collaborations in comparative effectiveness research: opportunities and challenges for social network analysis.
    Zickafoose JS; Kimmey LD; Tomas A; Esposito D; Rich E
    J Comp Eff Res; 2014 Nov; 3(6):667-75. PubMed ID: 25494573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A push for comparative effectiveness: US initiatives aim to empower patients, physicians. Interview by Bridget M. Kuehn.
    Clancy CM
    JAMA; 2012 Apr; 307(15):1570-1. PubMed ID: 22511672
    [No Abstract]   [Full Text] [Related]  

  • 18. American Recovery and Reinvestment Act investments in data infrastructure.
    O'Day B; Kieffer T; Forrestal S; Esposito D
    J Comp Eff Res; 2014 Nov; 3(6):591-600. PubMed ID: 25494565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness research in radiology: patients, physicians and policy makers.
    Rawson JV
    Acad Radiol; 2011 Sep; 18(9):1067-71. PubMed ID: 21420332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infrastructure to support learning health systems: are we there yet? Innovative solutions and lessons learned from American Recovery and Reinvestment Act CER investments.
    Holve E; Segal C
    J Comp Eff Res; 2014 Nov; 3(6):635-45. PubMed ID: 25494570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.